LOADING
Comparing Mastercard Inc (MA) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $440.4B | $585.7B |
| P/E Ratio | 29.9 | 22.0 |
| Forward P/E | 25.2 | 21.1 |
| PEG Ratio | 1.58 | 1.70 |
| EPS | $16.53 | $11.03 |
| Revenue Growth (YoY) | 17.6% | 9.1% |
| Profit Margin | 45.7% | 28.5% |
| Return on Equity | 209.9% | 35.0% |
| Dividend Yield | 0.64% | 2.11% |
| Beta | 0.83 | 0.33 |
| 52-Week High | $600.08 | $251.71 |
| 52-Week Low | $462.92 | $137.67 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.